Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders
Psychiatric Clinics of North America · 2026-03 · 49 (1) · 183-202
DOI: 10.1016/j.psc.2025.08.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatric Clinics of North America, 2026-03. Verfasst von Lauren M Schaefer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, Unive…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Feeding and Eating Disorders, Glucagon-Like Peptides, Binge-Eating Disorder. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, Novo Nordisk.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, University of North Dakota School of Medicine and Health Sciences. Electron…
- Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, University of North Dakota School of Medicine and Health Sciences; Departme…
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 3029, Philadelphia, PA 19104-3309, USA.
- Sanford Eating Disorders and Weight Management Center, 1717 S University Drive, Fargo, ND 58103, USA.
- Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Pharmaceutical Sciences, North Dakota State University, 401 Albrecht Boulevard.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- Novo Nordisk
- Nordisk Atlantsamarbejde
Zitieren
APA
Schaefer, L. M., Kerver, G. A., Allison, K. C., Kohoutek, B., & Steffen, K. J. (2026). Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders. Psychiatric Clinics of North America, 49(1), 183-202. https://doi.org/10.1016/j.psc.2025.08.013
Vancouver
Schaefer LM, Kerver GA, Allison KC, Kohoutek B, Steffen KJ. Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders. Psychiatric Clinics of North America. 2026;49(1):183-202. doi:10.1016/j.psc.2025.08.013
BibTeX
@article{Schaefer2026,
author = {Schaefer, Lauren M and Kerver, Gail A and Allison, Kelly C and Kohoutek, Bradley and Steffen, Kristine J},
title = {Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders},
journal = {Psychiatric Clinics of North America},
year = {2026},
volume = {49},
number = {1},
pages = {183--202},
doi = {10.1016/j.psc.2025.08.013}
}
EUVIMED